SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (528)3/2/2000 10:14:00 PM
From: Tom Hua  Respond to of 1475
 
Richard, thanks for your work. Much appreciated. I really like BTRN's "slow" upward movement. Slow in comparison to some other biotechs, but still a 50% gain from my buy at 14 just weeks ago. The day we see a 1-million share volume, BTRN will probably in the 40s.

Regards,

Tom



To: scaram(o)uche who wrote (528)3/6/2000 10:33:00 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 1475
 
personalwealth.com

Principal experimental products in the company's R&D pipeline include anti-CD2 humanized monoclonal antibody for psoriasis and graft-vs.-host disease


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News